These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


628 related items for PubMed ID: 12915670

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.
    Burnett-Bowie SA, McKay EA, Lee H, Leder BZ.
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4785-92. PubMed ID: 19820017
    [Abstract] [Full Text] [Related]

  • 23. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L, Kohlmeier L, Kent K, Marcus R.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [Abstract] [Full Text] [Related]

  • 24. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa.
    Audí L, Vargas DM, Gussinyé M, Yeste D, Martí G, Carrascosa A.
    Pediatr Res; 2002 Apr; 51(4):497-504. PubMed ID: 11919336
    [Abstract] [Full Text] [Related]

  • 25. Novel treatment of delayed male puberty with aromatase inhibitors.
    Dunkel L, Wickman S.
    Horm Res; 2002 Apr; 57 Suppl 2():44-52. PubMed ID: 12065927
    [Abstract] [Full Text] [Related]

  • 26. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
    Marttunen MB, Hietanen P, Tiitinen A, Ylikorkala O.
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
    [Abstract] [Full Text] [Related]

  • 27. Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition.
    Hero M, Ankarberg-Lindgren C, Taskinen MR, Dunkel L.
    Eur J Endocrinol; 2006 Sep; 155(3):453-60. PubMed ID: 16914600
    [Abstract] [Full Text] [Related]

  • 28. Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats.
    Mohamed I, Yeh JK.
    J Endocrinol; 2009 Aug; 202(2):317-25. PubMed ID: 19420010
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
    Krupa B.
    Ann Acad Med Stetin; 2000 Aug; 46():165-76. PubMed ID: 11712302
    [Abstract] [Full Text] [Related]

  • 30. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
    Guo CY, Jones TH, Eastell R.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
    [Abstract] [Full Text] [Related]

  • 31. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
    Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kröger H.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3174-81. PubMed ID: 10487683
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men.
    Christmas C, O'Connor KG, Harman SM, Tobin JD, Münzer T, Bellantoni MF, Clair CS, Pabst KM, Sorkin JD, Blackman MR.
    J Gerontol A Biol Sci Med Sci; 2002 Jan; 57(1):M12-8. PubMed ID: 11773207
    [Abstract] [Full Text] [Related]

  • 34. Bone metabolism markers and ghrelin in boys at different stages of sexual maturity.
    Jürimäe J, Pomerants T, Tillmann V, Jürimäe T.
    Acta Paediatr; 2009 May; 98(5):892-6. PubMed ID: 19243352
    [Abstract] [Full Text] [Related]

  • 35. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 36. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
    Rochira V, Zirilli L, Madeo B, Aranda C, Caffagni G, Fabre B, Montangero VE, Roldan EJ, Maffei L, Carani C.
    Bone; 2007 Jun 15; 40(6):1662-8. PubMed ID: 17400043
    [Abstract] [Full Text] [Related]

  • 37. The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals.
    van Kesteren P, Lips P, Deville W, Popp-Snijders C, Asscheman H, Megens J, Gooren L.
    J Clin Endocrinol Metab; 1996 Jun 15; 81(6):2227-32. PubMed ID: 8964856
    [Abstract] [Full Text] [Related]

  • 38. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men.
    Gennari L, Merlotti D, Martini G, Gonnelli S, Franci B, Campagna S, Lucani B, Dal Canto N, Valenti R, Gennari C, Nuti R.
    J Clin Endocrinol Metab; 2003 Nov 15; 88(11):5327-33. PubMed ID: 14602769
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR, Smals AG, Swinkels LM, Huysmans DA, Pieters GF, Sweep CF, Corstens FH, Kloppenborg PW.
    J Clin Endocrinol Metab; 1995 Oct 15; 80(10):2859-65. PubMed ID: 7559865
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 32.